Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Does the presence of LCIS on pathology in a patient with IDC impact your decision to offer APBI?
Related Questions
For a young female (<40) with HR-/HER2+ cT1-2N1, ypT1aN0 s/p mastectomy with SLNB, would you offer PMRT?
How would you approach radiation for an elderly patient with pT2N1 TNBC s/p MRM and ALND who refused chemo-immunotherapy?
What dose of reirradiation would you consider for locally recurrent breast cancer after mastectomy, excised with positive margins?
Do you hold endocrine therapy during adjuvant breast radiotherapy?
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
When using FAST Forward, how important is it for the treatment to be delivered Monday through Friday in one week as opposed to spanning a weekend?
What is your preferred method of surveillance after mastectomy?
Is there any contraindication for a patient receiving omalizumab for treatment of her lung aspergillosis to receive adjuvant breast radiotherapy?
Do you recommend re-excision of a unifocal positive anterior margin at skin after lumpectomy in a patient with otherwise low risk breast cancer features?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
